SLC7A11 and Hepatic fibrosis: Wogonoside activated ferroptosis by decreasing the levels of solute carrier family 7 member 11 (SLC7A11), GPX4, and GSH in mouse HSC-T6 cells, while reducing the levels of α-smooth muscle actin (α-SMA) with COL1A1 and alleviating liver fibrosis [16].